| Autor: |
Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Migkou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Bhutani M; Atrium Health, Levine Cancer Institute, Charlotte, NC, USA., Ailawadhi S; Mayo Clinic, Jacksonville, FL, USA., Kalff A; The Alfred Hospital, Melbourne, Australia., Walcott FL; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Pore N; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Brown M; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Wang F; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Cheng LI; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Kagiampakis I; Translational Medicine Bioinformatics, AstraZeneca, Gaithersburg, MD, USA., Williams M; Translational Medicine, AstraZeneca, Gaithersburg, MD, USA., Kinneer K; Translational Medicine, AstraZeneca, Gaithersburg, MD, USA., Wu Y; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Jiang Y; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Kubiak RJ; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Zonder JA; Karmanos Cancer Institute, Detroit, MI, USA., Larsen J; Mayo Clinic, Scottsdale, AZ, USA., Sirdesai S; The Alfred Hospital, Melbourne, Australia., Yee AJ; Massachusetts General Hospital, Boston, MA, USA., Kumar S; Mayo Clinic, Rochester, MN, USA. |
